Delivery Order SPE2DR25D2106-SPE2DR26F1GNS

<p>The Defense Logistics Agency issued a delivery order to Amerisourcebergen Drug Corp on February 5, 2026, for Xcopri 200 mg tablets (30-count) with a ceiling value of $3,728.73.</p> <p>Place of performance is Conshohocken, PA. The ultimate completion date is February 6, 2026. The order is priced on a firm fixed-price basis with no set-aside.</p>

The Defense Logistics Agency issued a delivery order to Amerisourcebergen Drug Corp on February 5, 2026, with a ceiling value of $5,280.21 for the supply of Xcopri 100 mg tablets (30-count units). Place of performance is Conshohocken, PA. The order is issued under the parent Indefinite Delivery Contract with DLA Troop Support Medical, valued at up to $999,999,999.00 through December 2026, which supports pharmaceutical and medical supply procurement for military healthcare programs worldwide....

The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 8, 2025, for the supply of Xcopri 100 mg tablets (30-count units) valued at $3,536.88. This is a firm fixed-price delivery order with no set-aside designation, classified as a competitive award. The contract has an ultimate completion date of August 11, 2025, and performance will be executed at AmerisourceBergen's Corporate Office facility in Conshohocken, Pennsylvania. This delivery order is issued...

The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on September 5, 2025, for the supply of Xcopri 150 mg tablets (30-count units) with a ceiling value of $1,800.99. This competitively awarded, firm fixed-price delivery order is scheduled for ultimate completion by September 8, 2025, and will be performed at the contractor's Conshohocken, Pennsylvania location. No set-aside designation was applied to this procurement. This delivery order is issued under...

<p>The Defense Logistics Agency issued a $3,059.88 delivery order to Amerisourcebergen Drug Corp on February 5, 2026, for XCOPRI 200 mg tablets (30-count).</p> <p>Place of performance is Conshohocken, PA. The order is firm fixed price with an ultimate completion date of February 6, 2026. No set-aside was used.</p>

The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on February 3, 2026, for the supply of Xcopri 200 mg tablets (30-count units) with a contract value of $1,354.14. This is a firm fixed-price delivery order with no set-aside designation, indicating the award was made through full and open competition. The place of performance is Conshohocken, Pennsylvania, where AmerisourceBergen maintains its corporate headquarters. The contract has an ultimate completion...

The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 19, 2025, for the supply of Xcopri 150 mg tablets (30-count units) under a firm fixed price contract valued at $1,393.98. This non-set-aside, competitively awarded delivery order has an ultimate completion date of August 20, 2025, and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The award represents a single line item procurement of this neurological...

On January 30, 2026, the Defense Logistics Agency (DLA) awarded a delivery order valued at $1,793.06 to AmerisourceBergen Drug Corp for the supply of Xcopri 200 mg tablets (30-count). This non-set-aside, competitively awarded contract employs firm fixed-price pricing and is scheduled for completion by February 2, 2026. The place of performance is located in Conshohocken, Pennsylvania, where AmerisourceBergen Drug Corp maintains its corporate headquarters. This delivery order is issued under...

The Defense Logistics Agency awarded a $3,927.06 delivery order to AmerisourceBergen Drug Corp for Xcopri 200 mg tablets (30-count units) on September 2, 2025, with an ultimate completion date of September 3, 2025. This non-set-aside contract is structured as a firm fixed price delivery order to be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. Xcopri is a prescription anticonvulsant medication used in epilepsy treatment, reflecting the Defense...

The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 7, 2025, for the supply of Xcopri 200 mg tablets (30-count packaging) with a ceiling value of $2,483.14. This is a firm fixed-price delivery order with an ultimate completion date of August 8, 2025, and represents a non-set-aside, competitively awarded contract. The award specifies performance at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is...